Cited by 515Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsCardiac tumors and thrombi

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

Open access

Strauss, S.J., Frezza, A.M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J.Y., Bolle, S., Bonvalot, S., Boukovinas, I., Bovee, J.V.M.G., Boye, K., Brennan, B., Brodowicz, T., Buonadonna, A., de Álava, E., Dei Tos, A.P., Garcia del Muro, X., Dufresne, A., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Gaspar, N., Gasperoni, S., Gelderblom, H., Gouin, F., Grignani, G., Gronchi, A., Haas, R., Hassan, A.B., Hecker-Nolting, S., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R.L., Jungels, C., Jutte, P., Kager, L., Kasper, B., Kawai, A., Kopeckova, K., Krákorová, D.A., Le Cesne, A., Le Grange, F., Legius, E., Leithner, A., López Pousa, A., Martin-Broto, J., Merimsky, O., Messiou, C., Miah, A.B., Mir, O., Montemurro, M., Morland, B., Morosi, C., Palmerini, E., Pantaleo, M.A., Piana, R., Piperno-Neumann, S., Reichardt, P., Rutkowski, P., Safwat, A.A., Sangalli, C., Sbaraglia, M., Scheipl, S., Schöffski, P., Sleijfer, S., Strauss, D., Sundby Hall, K., Trama, A., Unk, M., van de Sande, M.A.J., van der Graaf, W.T.A., van Houdt, W.J., Frebourg, T., Ladenstein, R., Casali, P.G., Stacchiotti, S.·2021·Annals of Oncology

DOI 10.1016/j.annonc.2021.08.1995

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.annonc.2021.08.1995

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

AJCC Cancer Staging Manual
(2016) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,300
A System for the Surgical Staging of Musculoskeletal Sarcoma
Enneking, W. F., Spanier, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,661
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I. P., Bovée, J. V. M. G., Brodowicz, T., Broto, J. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy096 · Cited by 1,615
Self-citation
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.006 · Cited by 1,115
Self-citation
Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group
Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,035
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
Amary, M. F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., Pollock, R., O'Donnell, P., Grigoriadis, A., Diss, T., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2913 · Cited by 1,023
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Self-citation
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Behjati, S., Tarpey, P. S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., Wedge, D. C., Cooke, S. L., Gundem, G., Davies, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2814 · Cited by 854
Self-citation
Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Womer, R. B., West, D. C., Krailo, M., Dickman, P. S., Pawel, B., Grier, H. E., Marcus, K. J., Sailer, S. L., Healey, J. H., Dormans, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5703 · Cited by 761
Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752

Show all 99 references

Sorted by citations

Items 101–200 of 515

Cellular Senescence-Related Long Non-coding RNA Signatures Predict Prognosis in Juvenile Osteosarcoma
Zhao, P., Chang, J., Chen, Y.-J., Sun, X., Ma, X., Zhou, C., Zhou, L., Wang, Y., & Yang, Y. (2024) · Phenomics · doi:10.1007/s43657-023-00132-y · Cited by 9
Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas
Oblinger, J. L., Wang, J., Wetherell, G. D., Agarwal, G., Wilson, T. A., Benson, N., Fenger, J. M., Fuchs, J. R., Kinghorn, A. D., & Chang, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-69171-3 · Cited by 9
Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Jehanno, N., Corradini, N., Gaspar, N., Brahmi, M., Valentin, T., Revon‐Rivière, G., Lervat, C., Probert, J., Entz‐Werlé, N., Mansuy, L., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02864-8 · Cited by 9
Self-citation
Real world data of Ewing sarcoma from a resource-limited setting with poor compliance to treatment leading to poor outcomes
Gupta, N., Dimri, K., Garg, S. K., Arora, A., & Pandey, A. K. (2024) · ecancermedicalscience · doi:10.3332/ecancer.2024.1801 · Cited by 9
Beyond the sarcoma center: establishing the Sarcoma HASM network—a Hub and Spoke Model network for global integrated and precision care
Fuchs, B., & Gronchi, A. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103734 · Cited by 9
Self-citation
Anti-osteosarcoma activity of Corynoline via Src/JNK signaling-mediated cell cycle arrest and mitochondrial apoptosis
Li, M., Jiao, J., Jiang, W., Yu, T., Wang, Y., Wang, Z., & Wu, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114126 · Cited by 9
TFRC promotes the proliferation, migration, and invasion of osteosarcoma cells by increasing the intracellular iron content and RRM2 expression
Ren, G., Zhou, J., Su, Y., Yang, Q., & Li, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1567216 · Cited by 9
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group
D’Ambrosio, L., Sbaraglia, M., Merlini, A., Rabino, M., Grignani, G., Appolloni, V., Badalamenti, G., Baldi, G. G., Bellan, E., Benelli, M., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104960 · Cited by 9
Self-citation
A Tailored Approach for Appendicular Impending and Pathologic Fractures in Solid Cancer Metastases
do Brito, J. S., Lopes-Brás, R., Abrunhosa-Branquinho, A. N., Fernandes, I., Gomes, I., Casimiro, S., & Costa, L. (2022) · Cancers · doi:10.3390/cancers14040893 · Cited by 10
Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results
Chodyla, M.-K., Barbato, F., Dirksen, U., Kirchner, J., Schaarschmidt, B. M., Schweiger, B., Forsting, M., Herrmann, K., Umutlu, L., & Grueneisen, J. S. (2022) · Diagnostics · doi:10.3390/diagnostics12102278 · Cited by 9
A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma
Zhao, C., Tan, T., Zhang, E., Wang, T., Gong, H., Jia, Q., Liu, T., Yang, X., Zhao, J., Wu, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1029670 · Cited by 9
Investigation of the Incidence and Geographic Distribution of Bone and Soft Tissue Sarcomas in Canada: A National Population-Based Study
Alkazemi, B., Ghazawi, F. M., Lagacé, F., Nechaev, V., Zubarev, A., & Litvinov, I. V. (2023) · Current Oncology · doi:10.3390/curroncol30060424 · Cited by 9
Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
Bertin, H., Peries, S., Amiaud, J., Acker, N. V., Perrot, B., Bouvier, C., Aubert, S., Marie, B., Larousserie, F., Pinieux, G. D. B. D., et al. (2023) · Cancers · doi:10.3390/cancers15041004 · Cited by 8
Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years
Tichánek, F., Försti, A., Hemminki, O., Hemminki, A., & Hemminki, K. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102449 · Cited by 8
Lipid metabolism-derived FAAH is a sensitive marker for the prognosis and immunotherapy of osteosarcoma patients
Shi, Y., Wu, S. J., Zhang, X., Cao, Y., & Zhang, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23499 · Cited by 8
Advances in drug resistance of osteosarcoma caused by pregnane X receptor
Mao, K., Liu, C., Tang, Z., Rao, Z.-Z., & Wen, J. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2366948 · Cited by 8
Twenty-five years of experience with patient-reported outcome measures in soft-tissue sarcoma patients: a systematic review
Generaal, J. D., Jansen, M. R., van Leeuwen, G. L., van Ginkel, R. J., Been, L. B., & van Leeuwen, B. L. (2024) · Quality of Life Research · doi:10.1007/s11136-024-03755-4 · Cited by 8
18F-FDG PET Metabolic Parameters for the Prediction of Histological Response to Induction Chemotherapy in Osteosarcoma and Ewing Sarcoma
Yadgarov, M. Y., Бондоевич, Б. Л., Ракова, Е., & Likar, Y. (2024) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005412 · Cited by 8
Incidence and centralization of chordoma in the Netherlands: A nationwide study between 1991 and 2020
Lipplaa, A., van der Wal, R. J. P., Krol, A. D. G., Peul, W. C., Bovée, J. V. M. G., & Gelderblom, H. A. J. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102527 · Cited by 7
Self-citation
Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone Tumors
Berenguer-Rubio, A., Such, E., Hernández, N. T., González‐Rojo, P., Díaz‐González, Á., Avetisyan, G., Gil-Aparicio, C., González-López, J., Borja, N. S. P., Rubio-Martínez, L. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062820 · Cited by 7
Quality appraisal of radiomics-based studies on chondrosarcoma using METhodological RadiomICs Score (METRICS) and Radiomics Quality Score (RQS)
Gitto, S., Cuocolo, R., Klontzas, M. E., Albano, D., Messina, C., & Sconfienza, L. M. (2025) · Insights into Imaging · doi:10.1186/s13244-025-02016-3 · Cited by 7
The prognostic role of sarcopenia and muscle wasting in adult osteosarcoma patients: A longitudinal CT morphometric analysis
Kylies, J., Ballhause, T. M., Striefler, J. K., Kylies, D., & Priemel, M. (2025) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2025.110293 · Cited by 7
Bone Reporting and Data System on MRI (Bone-RADS-MRI): a validation study by four readers on 275 cases from three local and two public databases
Xing, Y., Hu, Y., Liu, X., Ding, D., Dai, S., Lyu, L., Zhang, G., Mao, S., Yin, Q., Lu, J. A., et al. (2025) · Insights into Imaging · doi:10.1186/s13244-025-02040-3 · Cited by 7
Bone reporting and data system on CT (Bone-RADS-CT): a validation study by four readers on 328 cases from three local and two public databases
Xing, Y., Ding, D., Dai, S., Hu, Y., Liu, X., Lyu, L., Zhang, G., Mao, S., Yin, Q., Lu, J. A., et al. (2025) · Insights into Imaging · doi:10.1186/s13244-025-02057-8 · Cited by 7
Radiomics for bone tumour diagnosis and management
Molinari, V., Gitto, S., Serpi, F., Fusco, S., Albano, D., Messina, C., FABBRO, M. D., Peretti, G. M., & Sconfienza, L. M. (2025) · Clinical Radiology · doi:10.1016/j.crad.2025.107062 · Cited by 7
Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment
Dong, Y., Wang, L., Zhang, H., Li, M., Luo, Z. Y., Hu, Y., & Cai, C.-Y. (2025) · Advanced Science · doi:10.1002/advs.202512363 · Cited by 8
Comparative outcomes of neoadjuvant chemotherapy versus upfront surgical resection in osteosarcoma: a systematic review and meta-analysis
Alaseem, A., Alanezi, M. N., Almehrij, F., Alanezi, K., Alrasheed, K. F., Alrefaei, N., Alshaygy, I. S., Albishi, W., & Al-Hashem, H. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-04115-3 · Cited by 7
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial
Jones, R. L., Groisberg, R., Blay, J., Colman, H., Fuente, M. D. L., Roxburgh, P., Chao, M. M., Tian, H., Duffaud, F., Bahleda, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68716-6 · Cited by 7
Self-citation
Genomic Characterization of Rare Primary Cardiac Sarcoma Entities
Gozzellino, L., Nannini, M., Pizzi, C., Leone, O., Corti, B., Indio, V., Baldovini, C., Paolisso, P., Foà, A., Pacini, D., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13020214 · Cited by 7
Self-citation
Narrative Medicine: A Digital Diary in the Management of Patients with Bone and Soft Tissue Sarcoma—A Multidisciplinary Pilot Study
Cercato, M. C., Onesti, C. E., Vari, S., Maggi, G., Faltyn, W., Ceddia, S., Terrenato, I., Scarinci, V., Servoli, F., Cenci, C., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237218 · Cited by 7
Self-citation
Immune microenvironment and immunotherapy for chordoma
Chen, Y., & Zhang, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1374249 · Cited by 7
Improving Diagnosis and Care for Patients With Sarcoma: Do Real-World General Practitioners Data and Prospective Data Collections Have a Place Next to Clinical Trials?
Holthuis, E. I., Heins, M. J., van Houdt, W. J., Haas, R. L., Overbeek, J. A., Hartman, T. O., Uijen, A. A., Wee, L., van der Graaf, W. T. A., & Husson, O. (2024) · JCO Clinical Cancer Informatics · doi:10.1200/cci.24.00054 · Cited by 7
Self-citation
Genomic Insights Into High-Grade Infarct-Associated Bone Sarcomas
Tvrdik, T., Gjeorgjievski, S. G., Wong, P., Oskouei, S. V., Read, W., & Bahrami, A. (2024) · Modern Pathology · doi:10.1016/j.modpat.2024.100572 · Cited by 7
Global research trends and hotspots in metabolomics of osteosarcoma: a decade-spanning bibliometric and visualized analysis
Tu, J.-B., Liu, T., Li, J.-F., Long, J., Wang, X., Liu, W., & Gao, X.-H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1463078 · Cited by 7
Bayesian unsupervised clustering identifies clinically relevant osteosarcoma subtypes
Llaneza‐Lago, S., Fraser, W. D., & Green, D. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae665 · Cited by 7
Global and regional disparities in access to specialist sarcoma services
Zamora, T., Botello, E., Jenkins, T., Jeys, C., Laitinen, M., Puri, A., & Jeys, L. M. (2025) · Bone & Joint Open · doi:10.1302/2633-1462.64.bjo-2024-0208.r1 · Cited by 8
Prevalence, Risk Factors, and Prognostic Factors of Primary Malignant Bone Neoplasms with Bone Metastasis at Initial Diagnosis: A Population-Based Study
Xiao, Z.-W., Guo, H.-L., Chen, H., Yan, L.-P., Liao, Y.-L., Li, S.-L., Zhao, L., Su, L.-B., Li, J.-J., & Tang, F. (2022) · Journal of Oncology · doi:10.1155/2022/9935439 · Cited by 7
Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives
do Brito, J. S., Esperança‐Martins, M., Abrunhosa-Branquinho, A. N., Melo-Alvim, C., Lopes-Brás, R., Janeiro, J., Lopéz‐Presa, D., Fernandes, I., Portela, J., & Costa, L. (2022) · Cancers · doi:10.3390/cancers14102546 · Cited by 7
Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS)
Hecker‐Nolting, S., Baumhoer, D., Blattmann, C., Kager, L., Kühne, T., Kevric, M., Lang, S., Mettmann, V. L., Sorg, B., Werner, M., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04156-1 · Cited by 7
Self-citation
Exosomes in sarcoma: Prospects for clinical applications
Ye, H., Tan, L., Tu, C., & Min, L. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103895 · Cited by 7
A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial Results
Childs, A., Gerrand, C., Brennan, B. M. D., Young, R., Rankin, K. S., Parry, M., Stevenson, J. D., Flanagan, A. M., Taylor, R. M., Fern, L. A., et al. (2024) · Cancers · doi:10.3390/cancers16132351 · Cited by 6
Self-citation
The paradoxical role of stem cells in osteosarcoma: from pathogenesis to therapeutic breakthroughs
Su, Z., Fang, X., & Duan, H. Q. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1643491 · Cited by 7
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas
Pasquali, S., Collini, P., Romagosa, C., Coindre, J., Pizzamiglio, S., Verderio, P., Duroni, V., Barisella, M., Palmerini, E., Quagliuolo, V., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.40177 · Cited by 6
Self-citation
Multifunctional nanoplatforms deciphering immune resistance in bone tumors: cooperative delivery, immune reprogramming and microenvironment remodeling
Li, J., Yang, C., Wang, L., & Li, S. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04243-2 · Cited by 6
Muscle strength characteristics following megaprosthetic knee reconstruction for bone sarcoma
Johansen, M. L., Eriksrud, O., Thorkildsen, J., Norum, O.-J., Wisløff, T. F., Taksdal, I., & Nilsen, T. S. (2023) · Surgical Oncology · doi:10.1016/j.suronc.2023.101944 · Cited by 6
Necroptosis in the sarcoma immune microenvironment: From biology to therapy
Ye, H., Lu, M., Tu, C., & Li, M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110603 · Cited by 6
RETRACTED: Exploring the role of lactylation‐related genes in osteosarcoma: A deep dive into prognostic significance and therapeutic potential
Sun, J., Li, Y., Chen, R., Xie, Y., Wei, J., & Li, B. (2023) · Environmental Toxicology · doi:10.1002/tox.24011 · Cited by 6
Retracted
68Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results
Jena, S. R., Watts, A., Aggarwal, P., Bachhal, V., Kaur, H., Dhingra, K., Singh, H., Bal, A., & Singh, B. (2023) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001803 · Cited by 6
Relative Wash-In Rate in Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a New Prognostic Biomarker for Event-Free Survival in 82 Patients with Osteosarcoma: A Multicenter Study
Kalisvaart, G. M., Evenhuis, R. E., Grootjans, W., Berghe, T. V. D., Callens, M., Bovée, J. V. M. G., Creytens, D., Gelderblom, H. A. J., Speetjens, F. M., Lapeire, L., et al. (2024) · Cancers · doi:10.3390/cancers16111954 · Cited by 6
Self-citation
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling
Dupuy, M., Guéguinou, M., Postec, A., Brion, R., Tesfaye, R. A., Mullard, M., Regnier, L., Amiaud, J., Hubsch, C., Potier‐Cartereau, M., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03199-7 · Cited by 6
Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells
Li, B., Zhao, Q., Yang, H., Wang, X., Zhang, Z., Gong, Y., & Xu, W. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02992-7 · Cited by 6
Efficacy and safety of regorafenib in the treatment of bone sarcomas: systematic review and meta-analysis
Han, Y., Xie, J., Wang, Y., Liang, X., & Xie, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-13722-y · Cited by 6
Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone
Yao, Y., Lee, V. K. M., & Chen, E. S. (2025) · Journal of bone oncology · doi:10.1016/j.jbo.2025.100665 · Cited by 6
Amputation surgery associated with shortened survival in patients with localized extremity bone sarcoma
Yanagisawa, N., Matsuoka, M., Onodera, T., Iwasaki, K., Hamasaki, M., Ebata, T., Hosokawa, Y., Kondo, E., & Iwasaki, N. (2024) · Journal of Orthopaedics · doi:10.1016/j.jor.2024.03.017 · Cited by 6
Retroperitoneale Weichteilsarkome: Chirurgische Therapie
Willis, F. M., & Schneider, M. (2021) · Der Chirurg · doi:10.1007/s00104-021-01506-6 · Cited by 6
Transcriptomic-Based Classification Identifies Prognostic Subtypes and Therapeutic Strategies in Soft Tissue Sarcomas
Esperança‐Martins, M., Vasques, H., Ravasqueira, M. S., Lemos, M. M., Fonseca, F., Coutinho, D., López, J. A., Huang, R. S. P., Dias, S., Gallego-Paez, L. M., et al. (2025) · Cancers · doi:10.3390/cancers17172861 · Cited by 5
Pathology-interpretable radiomic model for predicting clinical outcome in patients with osteosarcoma: a retrospective, multicenter study
Ren, Q., Zhang, X., Wu, X., Zhao, H., Zhang, Y., Yao, Y., Leng, Y., Zhang, X., Liu, W., Xiao, J., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04424-0 · Cited by 5
Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma
Remiszewski, P., Wąż, J., Falkowski, S., Rutkowski, P. L., & Czarnecka, A. M. (2025) · Current Oncology · doi:10.3390/curroncol32110615 · Cited by 5
Self-citation
Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS)
Bielack, S., Andreou, D., Baumhoer, D., Blattmann, C., Friedel, G., Fröhlich, B., Harrabi, S., Kager, L., Kalle, T. V., Keßler, T., et al. (2026) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06405-5 · Cited by 5
Self-citation
Reproducibility and repeatability of quantitative T2 and T2* mapping of osteosarcomas in a mouse model
Roudi, R., Pisani, L. J., Pisani, F., Liang, T., & Daldrup-Link, H. E. (2024) · European Radiology Experimental · doi:10.1186/s41747-024-00467-9 · Cited by 5
The Critical Role of Stereotactic Body Radiation Therapy in Multimodal Treatment of Lung Metastasis from Bone and Soft Tissue Sarcomas
Longhi, A., Marrari, A., Tetta, C., Parmeggiani, A., Parise, O., Ferrari, C., Salvi, F., & Frezza, G. P. (2024) · Cancers · doi:10.3390/cancers16213593 · Cited by 5
Post-treatment late and long-term effects in bone sarcoma: A scoping review
Khan, K., Kane, K., Davison, Z., & Green, D. (2025) · Journal of bone oncology · doi:10.1016/j.jbo.2025.100671 · Cited by 5
BUB1 an Overexpressed Kinase in Sarcoma: Finding New Target Therapy for Osteosarcoma, Liposarcoma, Synovial Sarcoma, and Leiomyosarcoma
Olvera-Valencia, M., Luna-Maldonado, F., Juarez-Reyes, J., Saavedra, A. L., Coronel-Hernández, J., Millán-Catalán, O., Guzmán‐Gómez, D., Rodríguez-Izquierdo, F., Herrera, L. A., León, D. F. C.-D., et al. (2025) · Biomolecules · doi:10.3390/biom15071046 · Cited by 5
Parosteal osteosarcoma of the thumb: A case report and literature review
Rossetti, A., Fily, A., Dréano, T., ROPARS, M., & Maximen, J. (2022) · Hand surgery & rehabilitation · doi:10.1016/j.hansur.2022.01.005 · Cited by 5
A systematic review of radiomics in giant cell tumor of bone (GCTB): the potential of analysis on individual radiomics feature for identifying genuine promising imaging biomarkers
Zhong, J., Xing, Y., Zhang, G., Hu, Y., Ding, D., Ge, X., Pan, Z., Yin, Q., Zhang, H., Yang, Q., et al. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03863-w · Cited by 5
A case report of rib osteosarcoma and literature review
Hu, X., Bao, T., Yan, C., Zhu, Y., & Zheng, X. (2023) · The Clinical Respiratory Journal · doi:10.1111/crj.13686 · Cited by 5
Narlumosbart: First Approval
Dhillon, S. (2023) · Drugs · doi:10.1007/s40265-023-01985-3 · Cited by 5
Synchronous multifocal osteosarcoma: Report of 4 cases and literature review
Bulut, H., Kanay, E., Anarat, F. B., Yıldırım, A. N. T., & Özkan, K. (2024) · Surgery Case Reports · doi:10.1016/j.sycrs.2024.100062 · Cited by 5
Primary extra-skeletal Ewing’s sarcoma presenting as an epidural Soft Tissue Lesion causing cauda equina syndrome in an adolescent girl: a case report
Soni, A., Kareem, S. A., Ramachandraiah, M. K., Papanna, A. K. S., & Srinivasa, V. (2022) · Spinal Cord Series and Cases · doi:10.1038/s41394-021-00474-7 · Cited by 5
Primary malignant peripheral nerve sheath tumors of bone: a clinicopathologic reappraisal of 8 cases
Gambarotti, M., Righi, A., Sbaraglia, M., Cocchi, S., Benini, S., Magagnoli, G., Frisoni, T., Palmerini, E., Picci, P., & Tos, A. P. D. (2022) · Human Pathology · doi:10.1016/j.humpath.2022.02.003 · Cited by 5
Self-citation
Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature
Nasca, V., Frezza, A. M., Morosi, C., Buonomenna, C., Parafioriti, A., Zappalà, G., Bini, F., Casali, P. G., Loppini, M., & Stacchiotti, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.953149 · Cited by 5
Self-citation
Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies
Kahan, J., Martinez, C., & Tsien, C. I. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01097-w · Cited by 5
Receipt of Guideline-Concordant Care Is Associated With Improved Survival in Patients With Osteosarcoma in California: A Population-Based Analysis
Abrahão, R., Keegan, T. H. M., Maguire, F. B., Li, Q., Malogolowkin, M. H., Wong, S. L., Thorpe, S. W., Carr-Asher, J. R., Midboe, A. M., Randall, R. L., et al. (2024) · JCO Oncology Practice · doi:10.1200/op.23.00591 · Cited by 4
Development and Validation of the Bone Tumor Surgery Complexity Score
Frei, A., Schelling, G., Heesen, P., Giovanoli, P., & Fuchs, B. (2024) · Reports — Medical Cases Images and Videos · doi:10.3390/reports7020035 · Cited by 4
Unraveling the role of bisphenol A in osteosarcoma biology: insights into prognosis and immune microenvironment modulation
Shiyao, L., Yao, K., Jun, L., Yichen, L., Zhao, T., Longtao, Y., Zhou, H. W., & Kai, Z. (2024) · Discover Oncology · doi:10.1007/s12672-024-01280-x · Cited by 4
Osteosarcoma and Ewing Sarcoma of Bone: An Italian Mono-Institutional Epidemiological Study
Ferrari, C., Magagnoli, G., Laranga, R., Bianchi, G., Carretta, E., Cesari, M., Scotlandi, K., Baldini, N., Donati, D. M., & Gambarotti, M. (2025) · Diagnostics · doi:10.3390/diagnostics15030328 · Cited by 5
Do patient-specific cutting guides for pelvic and sacral tumour resection provide tumour-free bone margins?
Bourbotte-Salmon, F., Lataste, F., Massardier, É., ROPARS, M., Meurgey, A., Vaz, G., & Gouin, F. (2025) · Orthopaedics & Traumatology Surgery & Research · doi:10.1016/j.otsr.2025.104235 · Cited by 4
Self-citation
Electrochemotherapy in the Treatment of Bone Metastases: A Narrative Review
Feddal, A., Deschamps, F., Beunon, P., de Baère, T., Tselikas, L., & Bonnet, B. (2025) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-025-04077-9 · Cited by 4
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic review
Rubio‐San‐Simón, A., Wilson, W., Sironi, G., Deley, M. L., Palmerini, E., Gaspar, N., Piperno-Neumann, S., Hecker‐Nolting, S., Strauss, S. J., van Ewijk, R., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03118-x · Cited by 5
Self-citation
Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study
Fazel, M., Varnier, R., Vanacker, H., Penel, N., Watson, S., Verret, B., Valentin, T., Bompas, E., Waïssi, W., Meurgey, A., et al. (2025) · Cancer · doi:10.1002/cncr.70052 · Cited by 4
Self-citation
Deep learning for automated segmentation of central cartilage tumors on MRI
Gitto, S., Corti, A., van Langevelde, K., Cañete, A. N., Cincotta, A., Messina, C., Albano, D., Vignaga, C., Ferrari, L., Mainardi, L. T., et al. (2025) · European Radiology Experimental · doi:10.1186/s41747-025-00633-7 · Cited by 4
Joint EANM/SNMMI procedural guideline for paediatric bone hybrid imaging with 99mTc-labelled radiopharmaceuticals and [18F]fluoride
Rogasch, J. M. M., Vali, R., Borgwardt, L., States, L. J., Lim, R., Nadel, H. R., Piccardo, A., Roca-Bielsa, I., Biassoni, L., Zucchetta, P., et al. (2025) · EANM Innovation · doi:10.1016/j.eanmi.2025.100009 · Cited by 4
Lung nodules in pediatric osteosarcoma: calcification as the most reliable radiological indicator to confirm metastasis
Sánchez, H. M., Cañete, A., Mateos, D. S., Benavent, N., Fernández, J., Robles, A. S., Martin, C., Vázquez, J. G., Salom, M., Macián, A. M., et al. (2025) · Pediatric Radiology · doi:10.1007/s00247-025-06410-3 · Cited by 4
A review of immunotherapy for bone tumors
Wang, C., Chen, Z., Mo, H., Wang, J., & Zhou, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1580598 · Cited by 4
Attenuation-based ultra-low-dose lung computed tomography at 0.1 mSv to 0.3 mSv effective dose in children
Sturm, M.-J., Kellenberger, C. J., Rupcich, F., Tschauner, S., & el Zellner, M. (2026) · Pediatric Radiology · doi:10.1007/s00247-025-06503-z · Cited by 4
Ewing’s Sarcoma of the Breast in a Young Woman: A Case Report and Review of the Literature
Papi, S., Combi, F., Segattini, S., Accogli, S., Palma, E., Gambini, A., Andreotti, A., Luppi, G., & Tazzioli, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.915844 · Cited by 4
Imaging Recommendations for Diagnosis, Staging, and Management of Bone Tumors
Janu, A., Patra, A., Kumar, M. C., Gulia, A., Kulkarni, S. S., Shetty, N., Puri, A., Nayak, P. R., & Pruthi, M. (2023) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0042-1760313 · Cited by 4
Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma
Digklia, A., Dolcan, A., Kucharczyk, M. A., Jones, R. L., & Napolitano, A. (2023) · Cancer Management and Research · doi:10.2147/cmar.s362693 · Cited by 4
Self-citation
A deep learning model for accurately predicting cancer-specific survival in patients with primary bone sarcoma of the extremity: a population-based study
Cheng, D., Liu, D., Li, X., Mi, Z., Zhang, Z., Tao, W., Dang, J., Zhu, D., Fu, J., & Fan, H. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03291-6 · Cited by 5
Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma
Hou, Y., Wang, J., & Wang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1284406 · Cited by 4
Prognostic factors of sarcomas occurring in bone and joint: A SEER based study
Zhou, H., He, S., Zhang, D., Wang, J., Yang, X., Jiao, J., Xu, W., Yang, J. M., & Xiao, J. (2023) · Medicine · doi:10.1097/md.0000000000034231 · Cited by 4
The organization of care in pediatric radiotherapy across SIOP Europe affiliated centers: A multicenter survey in the framework of the ‘Joint Action on Rare Cancers’ project
Janssens, G. O. R. J., Timmermann, B., Laprie, A., Mandeville, H., Padovani, L., Chargari, C., Kearns, P. R., Kozhaeva, O., Kameric, L., Kienesberger, A., et al. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.110075 · Cited by 4
Efficacy of tyrosine kinase inhibitors in patients with advanced or metastatic sarcomas after prior chemotherapy: A meta-analysis
Li, W., Liu, L., Liang, Z., Lai, H., Wu, J., Zhang, H., & Fang, C. (2024) · Medicine · doi:10.1097/md.0000000000037423 · Cited by 4
A Retrospective Study of 291 Patients With Head and Neck Sarcomas: Treatment, Outcomes, and Prognostic Factors
Hikmet, R. G., Klug, T. E., Gade, S. D., Sandfeld‐Paulsen, B., & Pedersen, N. A. (2024) · Clinical Oncology · doi:10.1016/j.clon.2024.04.009 · Cited by 4
Ziyuglycoside II suppressed the progression of osteosarcoma by coordinating estrogen-related receptor gamma and p53 signaling pathway
Du, H., Wu, D., Zhang, T., Zhong, Y., Wu, K., Guo, X., Sheng, L., Huang, N., Gao, C., & Sun, R. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60847-8 · Cited by 4
Impact of environmental pollution on human health: Investigating the role of Polycyclic Aromatic Hydrocarbons in pediatric osteosarcoma
Xu, M., Xu, Y., Huang, Y., Shi, J., Yin, L., Tu, J., Yin, J.-Q., & Zou, C. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118693 · Cited by 4
Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma
Song, J., Yuan, X., Piao, L., Wang, J., Wang, P., Zhuang, M., Liu, J., & Liu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1072701 · Cited by 5
Clinicopathological and molecular genetic analysis of 13 cases of primary retroperitoneal Ewing sarcoma
Wei, X., Cheng, M., Wang, L., Teng, X., Guo, D., Xin, X., Chen, G., Siyuan, L., & Li, F. (2024) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2024.152321 · Cited by 4
Case report: Extraskeletal Ewing sarcoma with a germline pathogenic variant of SMARCA4
Kang, M.-C., Kong, S., Park, S.-Y., Park, S.-Y., Lee, E., Yoo, C. W., Kim, Y. H., Kim, H., & Choi, W. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1422605 · Cited by 4
Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group
Bodmer, N., Hecker‐Nolting, S., Friedel, G., Blattmann, C., Kager, L., Keßler, T., Kevric, M., Kühne, T., Mettmann, V. L., Müller‐Abt, P., et al. (2023) · Cancer · doi:10.1002/cncr.34744 · Cited by 4
Self-citation

Authors: Strauss, S. J., Frezza, A. M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Boye, K., Brennan, B., Brodowicz, T., Buonadonna, A., de Álava, E., Dei Tos, A. P., Garcia del Muro, X., Dufresne, A., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Gaspar, N., Gasperoni, S., Gelderblom, H., Gouin, F., Grignani, G., Gronchi, A., Haas, R., Hassan, A. B., Hecker-Nolting, S., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R. L., Jungels, C., Jutte, P., Kager, L., Kasper, B., Kawai, A., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Le Grange, F., Legius, E., Leithner, A., López Pousa, A., Martin-Broto, J., Merimsky, O., Messiou, C., Miah, A. B., Mir, O., Montemurro, M., Morland, B., Morosi, C., Palmerini, E., Pantaleo, M. A., Piana, R., Piperno-Neumann, S., Reichardt, P., Rutkowski, P., Safwat, A. A., Sangalli, C., Sbaraglia, M., Scheipl, S., Schöffski, P., Sleijfer, S., Strauss, D., Sundby Hall, K., Trama, A., Unk, M., van de Sande, M. A. J., van der Graaf, W. T. A., van Houdt, W. J., Frebourg, T., Ladenstein, R., Casali, P. G., & Stacchiotti, S.
Affiliations: University College London Hospitals NHS Foundation Trust (GB)
Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Instituto Português de Oncologia Francisco Gentil (PT)
Homi Bhabha National Institute (IN)
University of Duisburg-Essen (DE)
Instituto Nazionale Tumori Regina Elena (IT)
Olgahospital (DE)
Centre Léon Bérard (FR)
Institut Gustave Roussy (FR)
Institut Curie (FR)
Oslo University Hospital (NO)
Royal Manchester Children's Hospital (GB)
Vienna General Hospital (AT)
Centro di Riferimento Oncologico (IT)
Skåne University Hospital (SE)
Ospedale Regina Margherita (IT)
Université Paris-Saclay (FR)
Azienda Ospedaliero-Universitaria Careggi (IT)
Leiden University Medical Center (NL)
Candiolo Cancer Institute (IT)
University of Milan (IT)
University of Oxford (GB)
Hospital Universitario Fundación Jiménez Díaz (ES)
University of Mannheim (DE)
University of Helsinki (FI)
Institute of Cancer Research (GB)
Université Libre de Bruxelles (BE)
University Medical Center Groningen (NL)
St Anna Children's Hospital (AT)
National Cancer Center Hospital (JP)
Masaryk Memorial Cancer Institute (CZ)
KU Leuven (BE)
University of Graz (AT)
Tel Aviv Sourasky Medical Center (IL)
Centre Hospitalier Universitaire Vaudois (CH)
Birmingham Women’s and Children’s NHS Foundation Trust (GB)
Istituto Ortopedico Rizzoli (IT)
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
Helios Hospital Berlin-Buch (DE)
The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Aarhus University Hospital (DK)
Azienda Ospedale - Università Padova (IT)
Universitair Ziekenhuis Leuven (BE)
Erasmus MC Cancer Institute (NL)
Royal Marsden Hospital (GB)
Institute of Oncology Ljubljana (SI)
ORCID: Strauss, S.J.
Frezza, A.M.
Bajpai, J.
Bauer, S.
Biagini, R.
Bielack, S.
Blay, J.Y.
Bolle, S.
Bonvalot, S.
Boye, K.
Brennan, B.
Buonadonna, A.
Dufresne, A.
Fagioli, F.
Ferraresi, V.
Ferrari, A.
Gaspar, N.
Gelderblom, H.
Gouin, F.
Grignani, G.
Gronchi, A.
Haas, R.
Hindi, N.
Hohenberger, P.
Joensuu, H.
Jones, R.L.
Jutte, P.
Kager, L.
Kasper, B.
Kawai, A.
Krákorová, D.A.
Legius, E.
Leithner, A.
Messiou, C.
Miah, A.B.
Mir, O.
Montemurro, M.
Morland, B.
Morosi, C.
Palmerini, E.
Pantaleo, M.A.
Piana, R.
Piperno-Neumann, S.
Reichardt, P.
Rutkowski, P.
Safwat, A.A.
Sangalli, C.
Sbaraglia, M.
Scheipl, S.
Schöffski, P.
Sleijfer, S.
Strauss, D.
Trama, A.
Unk, M.
Ladenstein, R.
Casali, P.G.
Stacchiotti, S.
Venue: Annals of Oncology
Publisher: Elsevier BV
Published: 2021-12
Volume: 32
Issue: 12
Pages: 1520-1536
ISSN: 0923-7534 (ISSN-L)
DOI: 10.1016/j.annonc.2021.08.1995
OpenAlex: W3197355167
Cited by: 513
References: 99
Citations by year: 2026: 137 · 2025: 118 · 2024: 111 · 2023: 88 · 2022: 54 · 2021: 4
FWCI: 41.84
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
Locations: Annals of Oncology (publishedVersion)
PubMed (publishedVersion)
Leiden Repository (Leiden University) (submittedVersion, cc-by)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
IRIS (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Lirias (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
SERVAL (Université de Lausanne) (submittedVersion)
Padua Research Archive (University of Padova) (submittedVersion)
Funders: European Society for Medical Oncology
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
Keywords: primary bone sarcoma, osteosarcoma, Ewing sarcoma, conventional chondrosarcoma, pediatric bone tumors, diagnosis, treatment, follow-up
MeSH terms: Bone Neoplasms, Follow-Up Studies, Humans, Sarcoma, Osteosarcoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks